Action Medical Research

Last updated
Action Medical Research
Founded1952
Founder Duncan Guthrie
Registration no.208701
FocusMedical Research into Children’s Diseases
Location
Key people
Charles Guthrie, Baron Guthrie of Craigiebank.
Website www.action.org.uk

Action Medical Research, previously The National Fund for Research into Crippling Diseases, is a British medical research charity, founded in 1952, that focusses on funding research to prevent and treat disease and disability in babies and children. [1] [2]

Contents

Action Medical Research is a registered charity No. 208701. [1] It is the leading UK-wide charity dedicated to saving and changing children’s lives through medical research.

They want to make a difference:

They do this by:

History

Founded in 1952 as the National Fund for Poliomyelitis Research by Duncan Guthrie, the charity's original aim was the eradication of polio. [2] During the 1940s and 1950s, epidemics of paralytic poliomyelitis were frequent in the UK, and the charity helped to fund the first British polio vaccine. [3] [4] After the steep reduction in paralytic poliomyelitis resulting from the introduction of the vaccine, the charity's activities diversified. It became The National Fund for Research into Poliomyelitis and Other Crippling Diseases in 1960 and The National Fund for Research into Crippling Diseases in 1967, becoming known informally as Action Research for the Crippled Child. It was renamed Action Research in 1990, and became Action Medical Research in 2003. [2] [5] The World Health Organization's 2002 declaration that Europe is free from polio coincided with the charity's fiftieth anniversary. [4]

The charity was founded in 1952 by Duncan Guthrie, who made it his mission to raise funds to defeat polio, a condition that affected the lives of many thousands of children including his own daughter Janet. His mission was realised when within 10 years, the first UK polio vaccines were introduced. Since then the charity has supported some of the most significant medical breakthroughs in recent history – breakthroughs that have helped save thousands of children’s lives and changed many more.

Projects and breakthroughs

Their major focus has been on pregnancy and conditions affecting babies, with involvement in projects including the rubella vaccine, ultrasound scanning in pregnancy, intrauterine blood typing, folic acid in the prevention of spina bifida, and the diagnosis of retinopathy in premature babies. Projects in older children include diet in liver disease and treatment of burns in children. Other projects include treatment for epilepsy. The charity has also been involved in hip replacement surgery and the development of aids for the elderly and severely disabled, including communication aids, the shapeable 'matrix' wheelchair and the 'Tools for Living' programme. The charity has also funded research into osteoporosis, nerve repair, hydrocephalus and myasthenia gravis.

The charity has supported some of the most significant medical breakthroughs in recent history – breakthroughs that have helped save thousands of children’s lives and changed many more.


Breakthroughs – helping more babies by:


Breakthroughs – supporting children with disabilities by:


Breakthroughs – protecting children from infections by:

Breakthroughs – finding the causes of and developing treatments for diseases by:

Fundraising activities

Action Medical Research raises funds through a variety of activities including, but not exclusive to, events, legacies, trust, weekly lottery, regular donations, appeals, and corporate support.

Related Research Articles

<span class="mw-page-title-main">Down syndrome</span> Genetic disorder

Down syndrome or Down's syndrome, also known as trisomy 21, is a genetic disorder caused by the presence of all or part of a third copy of chromosome 21. It is usually associated with developmental delays, mild to moderate intellectual disability, and characteristic physical features. There are three types of Down syndrome, the most common being Trisomy 21. Mosaic Down syndrome accounts for two per cent of Down syndrome cases, and Translocation Down syndrome accounts for three per cent of cases.

<span class="mw-page-title-main">Polio</span> Infectious disease caused by poliovirus

Poliomyelitis, commonly shortened to polio, is an infectious disease caused by the poliovirus. Approximately 75% of cases are asymptomatic; mild symptoms which can occur include sore throat and fever; in a proportion of cases more severe symptoms develop such as headache, neck stiffness, and paresthesia. These symptoms usually pass within one or two weeks. A less common symptom is permanent paralysis, and possible death in extreme cases. Years after recovery, post-polio syndrome may occur, with a slow development of muscle weakness similar to that which the person had during the initial infection.

<span class="mw-page-title-main">Rubella</span> Human viral disease

Rubella, also known as German measles or three-day measles, is an infection caused by the rubella virus. This disease is often mild, with half of people not realizing that they are infected. A rash may start around two weeks after exposure and last for three days. It usually starts on the face and spreads to the rest of the body. The rash is sometimes itchy and is not as bright as that of measles. Swollen lymph nodes are common and may last a few weeks. A fever, sore throat, and fatigue may also occur. Joint pain is common in adults. Complications may include bleeding problems, testicular swelling, encephalitis, and inflammation of nerves. Infection during early pregnancy may result in a miscarriage or a child born with congenital rubella syndrome (CRS). Symptoms of CRS manifest as problems with the eyes such as cataracts, deafness, as well as affecting the heart and brain. Problems are rare after the 20th week of pregnancy.

<span class="mw-page-title-main">Polio vaccine</span> Vaccine to prevent poliomyelitis

Polio vaccines are vaccines used to prevent poliomyelitis (polio). Two types are used: an inactivated poliovirus given by injection (IPV) and a weakened poliovirus given by mouth (OPV). The World Health Organization (WHO) recommends all children be fully vaccinated against polio. The two vaccines have eliminated polio from most of the world, and reduced the number of cases reported each year from an estimated 350,000 in 1988 to 33 in 2018.

<span class="mw-page-title-main">Post-polio syndrome</span> Human disease

Post-polio syndrome is a group of latent symptoms of poliomyelitis (polio), occurring at about a 25–40% rate. These symptoms are caused by the damaging effects of the viral infection on the nervous system. Symptoms typically occur 15 to 30 years after an initial acute paralytic attack. Symptoms include decreasing muscular function or acute weakness with pain and fatigue. The same symptoms may also occur years after a nonparalytic polio (NPP) infection.

<span class="mw-page-title-main">March of Dimes</span> American nonprofit organization

March of Dimes is a United States nonprofit organization that works to improve the health of mothers and babies. The organization was founded by President Franklin D. Roosevelt in 1938, as the National Foundation for Infantile Paralysis, to combat polio. The name "March of Dimes" was coined by Eddie Cantor. After funding Jonas Salk's polio vaccine, the organization expanded its focus to the prevention of birth defects and infant mortality. In 2005, as preterm birth emerged as the leading cause of death for children worldwide, research and prevention of premature birth became the organization's primary focus.

Ontario March of Dimes is a charitable organization which provides programs and services to people of all ages with physical disabilities in Ontario, Canada. Its headquarters is in Toronto. It is not affiliated with the American organization called March of Dimes.

Hypotonia is a state of low muscle tone, often involving reduced muscle strength. Hypotonia is not a specific medical disorder, but a potential manifestation of many different diseases and disorders that affect motor nerve control by the brain or muscle strength. Hypotonia is a lack of resistance to passive movement, whereas muscle weakness results in impaired active movement. Central hypotonia originates from the central nervous system, while peripheral hypotonia is related to problems within the spinal cord, peripheral nerves and/or skeletal muscles. Severe hypotonia in infancy is commonly known as floppy baby syndrome. Recognizing hypotonia, even in early infancy, is usually relatively straightforward, but diagnosing the underlying cause can be difficult and often unsuccessful. The long-term effects of hypotonia on a child's development and later life depend primarily on the severity of the muscle weakness and the nature of the cause. Some disorders have a specific treatment but the principal treatment for most hypotonia of idiopathic or neurologic cause is physical therapy and/or occupational therapy for remediation.

The following outline is provided as an overview of and topical guide to autism:

<span class="mw-page-title-main">Costello syndrome</span> Medical condition

Costello syndrome, also called faciocutaneoskeletal syndrome or FCS syndrome, is a rare genetic disorder that affects many parts of the body. It is characterized by delayed development and intellectual disabilities, distinctive facial features, unusually flexible joints, and loose folds of extra skin, especially on the hands and feet. Heart abnormalities are common, including a very fast heartbeat (tachycardia), structural heart defects, and overgrowth of the heart muscle. Infants with Costello syndrome may be large at birth, but grow more slowly than other children and have difficulty feeding. Later in life, people with this condition have relatively short stature and many have reduced levels of growth hormones. It is a RASopathy.

Dravet syndrome (DS), previously known as severe myoclonic epilepsy of infancy (SMEI), is an autosomal dominant genetic disorder which causes a catastrophic form of epilepsy, with prolonged seizures that are often triggered by hot temperatures or fever. It is very difficult to treat with anticonvulsant medications. It often begins before one year of age, with six months being the age that seizures, char­ac­ter­ized by prolonged convulsions and triggered by fever, usually begin.

<span class="mw-page-title-main">History of polio</span>

The history of polio (poliomyelitis) infections began during prehistory. Although major polio epidemics were unknown before the 20th century, the disease has caused paralysis and death for much of human history. Over millennia, polio survived quietly as an endemic pathogen until the 1900s when major epidemics began to occur in Europe. Soon after, widespread epidemics appeared in the rest of the world. By 1910, frequent epidemics became regular events throughout the developed world primarily in cities during the summer months. At its peak in the 1940s and 1950s, polio would paralyze or kill over half a million people worldwide every year.

<span class="mw-page-title-main">Gini Laurie</span>

Virginia Grace Wilson "Gini" Laurie was a central figure in the 20th century development, in the United States, of the independent living movement for people with disabilities. It is sometimes said that she was one of its two "grandmothers"—the other one being Mary Switzer, who was in charge of vocational rehabilitation at the national level from 1950 to 1970.

<span class="mw-page-title-main">Chickenpox</span> Human viral disease

Chickenpox, also known as varicella, is a highly contagious, vaccine-preventable disease caused by the initial infection with varicella zoster virus (VZV), a member of the herpesvirus family. The disease results in a characteristic skin rash that forms small, itchy blisters, which eventually scab over. It usually starts on the chest, back, and face. It then spreads to the rest of the body. The rash and other symptoms, such as fever, tiredness, and headaches, usually last five to seven days. Complications may occasionally include pneumonia, inflammation of the brain, and bacterial skin infections. The disease is usually more severe in adults than in children.

Mikhail Petrovich Chumakov was a Soviet Russian microbiologist and virologist most famous for conducting pivotal large-scale clinical trials that led to licensing of the Oral Polio Vaccine (OPV) developed by Albert B. Sabin.

<span class="mw-page-title-main">Biomedical sciences</span> Application of science to healthcare

Biomedical sciences are a set of sciences applying portions of natural science or formal science, or both, to develop knowledge, interventions, or technology that are of use in healthcare or public health. Such disciplines as medical microbiology, clinical virology, clinical epidemiology, genetic epidemiology, and biomedical engineering are medical sciences. In explaining physiological mechanisms operating in pathological processes, however, pathophysiology can be regarded as basic science.

Pakistan is one of the two remaining countries in the world where poliomyelitis (polio) is still categorized as an endemic viral infection, the other one being Afghanistan. While it has yet to fully eradicate Polio, there has been a downwards trend in the number of reported cases per year; the total count of wild poliovirus cases in Pakistan in 2019 was 147, compared to 84 in 2020, 1 in 2021, 20 in 2022, 6 in 2023 and 2 to date in 2024.

The Vaccine Damage Payment is a provision of the welfare state in the United Kingdom that provides a payment of £120,000, as of 2023, for people who can show that they have suffered a vaccine injury.

Polioencephalitis is a viral infection of the brain, causing inflammation within the grey matter of the brain stem. The virus has an affinity for neuronal cell bodies and has been found to affect mostly the midbrain, pons, medulla and cerebellum of most infected patients. The infection can reach up through the thalamus and hypothalamus and possibly reach the cerebral hemispheres. The infection is caused by the poliomyelitis virus which is a single-stranded, positive sense RNA virus surrounded by a non-enveloped capsid. Humans are the only known natural hosts of this virus. The disease has been eliminated from the U.S. since the mid-twentieth century, but is still found in certain areas of the world such as Africa.

<span class="mw-page-title-main">Announcement of polio vaccine success</span>

The announcement of the polio vaccine's safety and effectiveness was on April 12, 1955, by Thomas Francis, Jr., of the University of Michigan, the monitor of the test results. Within minutes of his announcement to the audience of scientists and reporters, news of the event was carried coast to coast by wire services and radio and television newscasts. When the vaccine was announced as successful, it led to spontaneous celebrations across the United States. It was the world's first successful polio vaccine, declared "safe, effective, and potent." It was possibly the most significant biomedical advance of the past century.

References